Matinas BioPharma to implement 1-for-15 reverse stock split
Matinas BioPharma approved a one-for-fifteen reverse stock split of its common stock effective Sept. 28, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.